Search

This photo essay showcases the critical role trainees play within MSK's research enterprise.

… Tuesday, September 3, 2024 The students and postdoctoral researchers who work and train in MSK’s laboratories drive discovery forward every day. Today they are vital partners. Tomorrow they will lead further progress at hospitals, research centers, and biomedical companies around the world.   Monica

People with bladder cancer may soon have a new treatment option following surgery.

… Thursday, May 13, 2021 Update: On August 19, 2021, the US Food and Drug Administration approved nivolumab for patients with bladder cancer who are at high risk of recurrence following surgery to remove the bladder.  People whose bladder cancer has spread into the muscle wall may soon have a new treatment

Learn how rectal cancer patients with HER2 driven tumors benefited from an early stage clinical trial at MSK.

… Saturday, April 18, 2026 A clinical trial at Memorial Sloan Kettering Cancer Center (MSK) is showing promise for people with early-stage rectal cancer whose tumors are driven by excessive amounts of a protein called HER2 (human epidermal growth factor receptor 2). The trial suggests that many of these

Dr. Clarkson of the Sloan Kettering Institute’s Molecular Pharmacology and Chemistry Program was recognized for his more than three decades of work on behalf of the AACR.

… Wednesday, June 6, 2012 Summary Dr. Clarkson of the Sloan Kettering Institute’s Molecular Pharmacology and Chemistry Program was recognized for his more than three decades of work on behalf of the AACR. Bayard D. Clarkson, of the Sloan Kettering Institute’s Molecular Pharmacology and Chemistry Program

Memorial Sloan Kettering Cancer Center (MSK) today celebrates its 26th year of the "holiday hallway." Each year during December, MSK’s carpenters, toolmakers, locksmiths, electricians, and painters construct a winter wonderland in the basement hallway of MSK for patients, families, and staff to visit and enjoy. The decades-long tradition brings joy and cheer to all and has grown in size and detail year after year. The “holiday hallway” is a labor of love for MSK’s Facilities staff, who give of themselves to create the magical MSK tradition. 

… Thursday, December 12, 2019 Today Show host, Hoda Kotb, takes a selfie with MSK’s Department of Facilities in MSK’s Holiday Hallway Today Show host, Hoda Kotb, takes a selfie with MSK’s Department of Facilities in MSK’s Holiday Hallway Memorial Sloan Kettering Cancer Center (MSK) today celebrates its

Several Memorial Sloan Kettering investigators are focused on the study of bacteria, which can teach us much about human health, and about cancer in particular.

… Tuesday, April 1, 2014 Summary Several Memorial Sloan Kettering investigators are focused on the study of bacteria, which can teach us much about human health, and about cancer in particular. At first glance, tiny single-celled bacteria could not be more different from humans. But there are many reasons

Degrees were presented and awards were given at the 38th annual ceremony held on May 18.

… Monday, May 22, 2017 Joan Massagué Sloan Kettering Institute Director Joan Massagué Yu Chen and Amanda Roxanne Moore Physician-scientist Yu Chen with graduate Amanda Roxanne Moore José Baselga, Charles Sawyers, and Andrew Kung Physician-in-Chief José Baselga, Human Oncology and Pathogenesis Program Chair

MSK's Dr. Caleb Lareau was awarded a 2026 Pershing Square Sohn Cancer Prize, which is designed to empower early-career investigators to pursue bold, high-impact projects.

… Tuesday, May 5, 2026 Memorial Sloan Kettering Cancer Center (MSK) computational biologist Caleb Lareau, PhD , has been awarded a 2026 Pershing Square Sohn Cancer Prize .  Dr. Lareau, whose lab at the Sloan Kettering Institute studies how cells in our bodies adapt, expand, and evolve during the course

By blocking a source of inflammation in the skin, it may be possible to prevent or treat lymphedema, a common and debilitating cancer complication.

… Wednesday, February 15, 2017 Summary Mounting evidence implicates inflammation as a cause of lymphedema, a common side effect of cancer treatment. Topical drugs that suppress this inflammation may hold promise as a therapy. Highlights Previous research has shown that immune cells promote the inflammation

Learn how MSK physician-scientist Christopher Klebanoff is working to bring immunotherapy to more patients, especially those with solid tumors.

… Wednesday, December 20, 2023 When Christopher Klebanoff, MD , came to Memorial Sloan Kettering Cancer Center (MSK) from the National Cancer Institute in 2016, he was focused on a singular goal: bringing the promise of cellular immunotherapies to the more than 80% of cancers that as yet lack an effective